Filter
657
Text search:
opioid
Featured
Recommendations
64
New Publications
142
Language
Document type
No document type
412
Guidelines
90
Studies & Reports
72
Manuals
27
Fact sheets
20
Strategic & Response Plan
14
Training Material
8
Situation Updates
7
Resource Platforms
3
Brochures
1
Infographics
1
Countries / Regions
India
51
Ukraine
23
Western and Central Europe
21
Asia
17
Global
17
Nepal
16
Kenya
14
Eastern Europe
14
Russia
11
Indonesia
9
Myanmar / Burma
9
Africa
9
South Africa
8
Bangladesh
8
South–East Asia Region
7
Tajikistan
7
Uganda
5
Tanzania
5
Latin America and the Carribbean
5
Albania
5
Georgia
5
Nigeria
4
Zambia
4
Cambodia
4
Armenia
4
Moldova
4
Ghana
3
Pakistan
3
Germany
3
Malawi
3
North Macedonia
3
Estonia
3
Liberia
2
Senegal
2
Ethiopia
2
Philippines
2
Afghanistan
2
Lebanon
2
Syria
2
Thailand
2
Serbia
2
Hungary
2
Libya
2
East and Southern Africa
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Bhutan
2
Kyrgyzstan
2
Vietnam
2
Morocco
1
Saudi Arabia
1
Haiti
1
Somalia
1
Iraq
1
Jordan
1
Egypt
1
Rwanda
1
Singapore
1
Mozambique
1
Sudan
1
Argentina
1
Eswatini/ Swaziland
1
Brazil
1
Colombia
1
Botswana
1
Mexico
1
Sri Lanka
1
Yemen
1
West and Central Africa
1
Western Pacific Region
1
Fiji
1
Solomon Islands
1
Poland
1
Palestine
1
Djibouti
1
Laos
1
Canada
1
Qatar
1
Romania
1
Iran
1
Kazakhstan
1
Jamaica
1
Norway
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
161
Clinical Guidelines
70
Public Health
21
Women & Child Health
21
Key Resources
7
Capacity Building
3
Pharmacy & Technologies
3
Toolboxes
HIV
236
Mental Health
121
TB
39
Pharmacy
34
COVID-19
19
Caregiver
18
NCDs
8
Conflict
6
Refugee
5
AMR
3
Social Ethics
3
Polio
2
NTDs
2
Natural Hazards
1
Rapid Response
1
Zika
1
Global Health Education
1
Planetary Health
1
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002462 November 28, 2017
Millennium Development Goal 8E aims for affordable access to essential medicines. Essential medicines, as defined by WHO, are those that “satisfy the health-care needs of the majority of the population” and that should therefore “be available at all times in adequate amounts”. However, there
...
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma
...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Evaluation report
September 2014
Ukraine Krise
recommended
Informationen rund um Einreise, Aufenthalt, medizinische Versorgung, aktuelle Updates für Geflüchtete aus der Ukraine und Behörden, Kommunen, Gemeinschaftsunterkünfte
Руководство предназначено для оказания помощи правительствам стран, в которых наблюдаются низкие уровни потребления контролируемых веществ, в исчислении их потр
...
With the goal of ending viral hepatitis as a public health threat by 2030, the Regional Action Plan will provide an actionable framework for implementing evidence-based interventions at scale. It will be informed through strategic monitoring of the response, that must be equitable and sustainable an
...
World Drug Report 2017
-5-
Accessed: 14.03.2019
EMCDDA Insights - 11
Accessed: 14.03.2019
World Drug Report 2018
-4-
Accessed: 24.09.2019
Accessed: 26.09.2019
World Psychiatry16:2 - June 2017
First published: 12 May 2017
https://doi.org/10.1002/wps.20428
Volume16, Issue2; Pages 213-214